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ABSTRACT 
Peste des Petits Ruminants (PPR) is a contagious viral disease of goats, sheep and 
wildlife in sub-Saharan African countries, Middle East and South-West of Asia. It is 
caused by a single strand negative RNA virus, belonging to the Paramyxoviridae family 
and Morbillivirus genus. Current vaccines consist of viral strains attenuated by several 
passages on cell cultures. These vaccines protect animais against PPR but do not permit 
the distinction between vaccinated and infected animais, a possibility which could 
improve surveillance and eradication of the disease. Development of reverse genetic to 
manipulate ncgative strand RNA genome is helping us to generate an infectious clone of 
PPR after cloning the whole genome of the PPR vaccine strain. Then, the objective is to 
mark this genome witb a negative tag by changing B epitopes on the N gene and a 
positive mark by insertion of a tag between P and M genes. A double marked vaccine of 
PPR is necessary for the discrimination of vaccinated, infected or vaccinated and 
concomitantly infected animais. Development of appropriate companion diagnosis tests 
are also in progress. 
INTRODUCTION 
Peste des Petits Ruminants (PPR) is a contagious viral disease of goats, 
sheep and wildlife in sub-Saharan African countries, Middle East and 
South-West of Asia. It is caused by a single strand negative RNA virus, 
belonging to the Paramyxoviridae family and Morbillivirus genus. Current 
vaccines consist of viral strains attenuated by several passages on cell 
cultures. These vaccines protect animals against PPR but do not permit the 
distinction between vaccinated and infected animais. Development of 
reverse genetic to manipulate negative strand RNA genome allows 
generating an infectious marked clone of PPR vaccine strain . 
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MATERIALS AND METHODS 
A rescue system with a minigenome containing the eGFP reporter gene 
was first generated. This gene was placed between the leader and trailer 
of PPRV in antisens position between the T7 polymerase promoter and 
terminator. This minigenome was co-transfected on 293-T7 cells 
(293 cells which expressed the T7 RNA polymerase) with 3 plasmids 
containing the N, P and L gene of PPRV to reconstitute the viral 
ribonucleoprotein complex. Four clones covering the full-length genome 
of PPRV were assembled in antisens orientation between T7 promoter 
and terminator into a modified pBluescript. This full length genome was 
co-transfected as previously described for the minigenome. Cells were 
harvested three days later, co-cultured on Vero cells and passaged until 
CPE developed. 
RESULTS 
The rescue system using the eGFP mm1genome and 293-T7 cells 
generated fluorescent cells, 3 days after transfection. These results were 
confirrned by detection of eGFP mRNA in transfected cells. The full 
length genome of PPRV vaccine strain was assembled and the sequence 
checked (this sequence was deposited in GenBank n°X74443). 
Generation of the first infectious clone of PPRV by reverse genetic is 
ongomg. 
DISCUSSION AND CONCLUSIONS 
The objective was to develop the reverse genetic for PPRV and to 
generate a first clone of PPRV. The rescue system based on the use of a 
minigenome expressing the eGFP was validated. Attempts to generate an 
infectious clone of PPRV from the full-length genome are ongoing. The 
final objective is to insert a mark in this genome and to develop 
appropriate companion diagnosis tests. 
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